Vistin Pharma ASA (FRA:VP4)
€ 2.02 0.02 (1%) Market Cap: 89.08 Mil Enterprise Value: 89.22 Mil PE Ratio: 17.44 PB Ratio: 3.43 GF Score: 75/100

Q1 2023 Vistin Pharma ASA Earnings Call Transcript

Apr 27, 2023 / 06:30AM GMT
Release Date Price: €1.75 (+0.29%)
Operator

Good day, and thank you for standing by. Welcome to the Vistin Pharma Quarterly Report Q1 2023 Conference Call. (Operator Instructions).

I would now like to hand the conference over to your speaker today, Kjell-Erik Nordby, CEO. Please go ahead, sir.

Kjell;Erik Nordby;Leave of Absence
Vistin Pharma ASA - CEO

()

Thank you very much. Welcome to this webcast presenting the first quarter 2023 results in Vistin Pharma. Now we start with the highlights for the quarter. We had a record high revenue in the quarter above NOK 100 million in revenue versus NOK 33 million in the first quarter last year. This significant increase in revenue is due to the fact that we are now producing material from both production lines, and that has resulted in more volumes available for sale compared to the 8-week production stop that we had in the first quarter last year when we did the MEP installation.

This record high revenue also has resulted in a high EBITDA for the quarter compared to the negative EBITDA on -- in first quarter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot